Healthcare provider profile · identity verified

Kishor Joshi, MD

Internal Medicine · AUSTIN, MN · NPI 1770005225

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	616	192
Amlodipine Besylate	Amlodipine Besylate	554	169
Lisinopril	Lisinopril	426	121
Levothyroxine Sodium	Levothyroxine Sodium	374	93
Metoprolol Succinate	Metoprolol Succinate	337	93
Omeprazole	Omeprazole	316	104
Losartan Potassium	Losartan Potassium	294	94
Metformin Hcl	Metformin Hcl	222	65
Gabapentin	Gabapentin	198	59
Simvastatin	Simvastatin	173	56
Furosemide	Furosemide	145	50
Metoprolol Tartrate	Metoprolol Tartrate	143	53
Metformin Hcl Er	Metformin Hcl	138	43
Torsemide	Torsemide	130	29
Tamsulosin Hcl	Tamsulosin Hcl	127	42
Hydrochlorothiazide	Hydrochlorothiazide	126	38
Pantoprazole Sodium	Pantoprazole Sodium	125	31
Sertraline Hcl	Sertraline Hcl	123	29
Warfarin Sodium	Warfarin Sodium	122	31
Rosuvastatin Calcium	Rosuvastatin Calcium	120	45
Trazodone Hcl	Trazodone Hcl	114	38
Ozempic	Semaglutide	112	24
Carvedilol	Carvedilol	109	34
Eliquis	Apixaban	106	34
Potassium Chloride	Potassium Chloride	106	33
Duloxetine Hcl	Duloxetine Hcl	99	27
Albuterol Sulfate Hfa	Albuterol Sulfate	86	40
Pregabalin	Pregabalin	86	32
Isosorbide Mononitrate Er	Isosorbide Mononitrate	82	21
Fluticasone Propionate	Fluticasone Propionate	81	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	77	34
Mirtazapine	Mirtazapine	74	26
Trulicity	Dulaglutide	73	15
Allopurinol	Allopurinol	71	20
Finasteride	Finasteride	69	21
Prednisone	Prednisone	66	33
Alendronate Sodium	Alendronate Sodium	62	22
Spironolactone	Spironolactone	61	20
Nitroglycerin	Nitroglycerin	59	33
Clopidogrel	Clopidogrel Bisulfate	57	16
Glipizide Er	Glipizide	57	17
Venlafaxine Hcl Er	Venlafaxine Hcl	57	14
Citalopram Hbr	Citalopram Hydrobromide	55	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	19
Montelukast Sodium	Montelukast Sodium	55	15
Oxycodone Hcl	Oxycodone Hcl	54	12
Jardiance	Empagliflozin	51	16
Lorazepam	Lorazepam	49	25
Paroxetine Hcl	Paroxetine Hcl	49	13
Chlorthalidone	Chlorthalidone	48	15
Pravastatin Sodium	Pravastatin Sodium	48	16
Buspirone Hcl	Buspirone Hcl	45	16
Xarelto	Rivaroxaban	44	15
Ezetimibe	Ezetimibe	43	12
Lactated Ringers	Ringer's Solution,lactated	42	suppressed
Magnesium Sulfate	Magnesium Sulfate	42	suppressed
Sodium Chloride	0.9 % Sodium Chloride	42	suppressed
Ventolin Hfa	Albuterol Sulfate	42	19
Esomeprazole Magnesium	Esomeprazole Magnesium	41	11
Tramadol Hcl	Tramadol Hcl	41	21
Clonazepam	Clonazepam	40	suppressed
Levetiracetam	Levetiracetam	40	suppressed
Glipizide	Glipizide	38	suppressed
Famotidine	Famotidine	36	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Atenolol	Atenolol	32	suppressed
Bupropion Xl	Bupropion Hcl	31	12
Baclofen	Baclofen	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	21
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	27	27
Mupirocin	Mupirocin	27	18
Ondansetron Odt	Ondansetron	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	26	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	21
Repatha Sureclick	Evolocumab	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Breyna	Budesonide/Formoterol Fumarate	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Lactulose	Lactulose	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Carbamazepine Er	Carbamazepine	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Np Thyroid	Thyroid,pork	20	suppressed
Nystatin	Nystatin	20	suppressed
Cefdinir	Cefdinir	19	18
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Topiramate	Topiramate	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Azithromycin	Azithromycin	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	14
Megestrol Acetate	Megestrol Acetate	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	13	suppressed
Oxazepam	Oxazepam	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Wegovy	Semaglutide	13	suppressed
Constulose	Lactulose	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error